FDA Approves Datroway®
On January 17, 2025, the FDA approved datopotamab deruxtecan-dlnk (Datroway®, Daiichi Sankyo, Inc.) for the treatment of people with hormone receptor-positive...
Read More PAST ARTICLES
2024
2023
2022
2021
SEARCH OUR SITE
for past articles or specific information.